TRIM63 and chronic kidney disease: Aligning with previous studies, these findings demonstrated that CKD activates proteolytic pathways, mainly dominated by the ubiquitin–proteasome system, fostering E3 ligases, such as Atrogin-1, coupled with MuRF-1 elevation and catabolic breakdown of muscle protein [49].